Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK3 | P52333 | 7/20 | 0.49 |
| ▸ | JAK2 | O60674 | 1/20 | 0.44 |
| ▸ | JAK1 | P23458 | 1/20 | 0.44 |
| ▸ | TTK | P33981 | 1/20 | 0.44 |
| ▸ | BTK | Q06187 | 1/20 | 0.43 |
| ▸ | MAP3K7 | O43318 | 3/20 | 0.43 |
| ▸ | FGFR1 | P11362 | 3/20 | 0.43 |
| ▸ | SRC | P12931 | 3/20 | 0.43 |
| ▸ | DDR2 | Q16832 | 1/20 | 0.42 |
| ▸ | EGFR | P00533 | 7/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | ITK | Q08881 | 4/20 | 0.41 |
| ▸ | BMX | P51813 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pebezertinib SCHEMBL29538098 | 0.96 | JAK3 (0.44) | JAK3JAK2JAK1TTKBTK | |
| Pebezertinib SCHEMBL24392854 | 0.95 | JAK3 (0.54) | JAK3JAK2JAK1TTKBTK | |
| Pebezertinib SCHEMBL29538037 | 0.91 | JAK3 (0.49) | JAK3JAK2JAK1TTKBTK | |
| SCHEMBL24392710 | 0.89 | JAK3 (0.53) | JAK3JAK2JAK1TTKBTK | |
| SCHEMBL24392761 | 0.89 | JAK3 (0.58) | JAK3JAK2JAK1TTKBTK | |
| SCHEMBL24393004 | 0.89 | JAK3 (0.54) | JAK3JAK2JAK1TTKBTK | |
| SCHEMBL29508107 | 0.89 | JAK3 (0.52) | JAK3JAK2JAK1TTKBTK | |
| SCHEMBL29538322 | 0.89 | JAK3 (0.58) | JAK3JAK2JAK1TTKBTK | |
| SCHEMBL29537886 | 0.88 | SYK (0.43) | JAK3JAK2JAK1DDR2KDR | |
| SCHEMBL29508185 | 0.88 | JAK3 (0.49) | JAK3JAK2JAK1TTKBTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4237418-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | Blueprint Medicines Corporation (US) | 2023-09-06 | — | — | EP | disclosed |
| WO-2022094354-A1 | PYRIMIDINE COMPOUNDS, COMPOSITIONS, AND MEDICINAL APPLICATIONS THEREOF | LENGO THERAPEUTICS, INC. (US) | 2022-05-05 | — | — | WO | disclosed |